Further confirmation of the avirulence of Streptococcus faecalis strain BIO-4R.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000917:Antibody Formation / Q000187:drug effects; D003520:Cyclophosphamide / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D013293:Enterococcus faecalis / Q000187:drug effects / Q000276:immunology / Q000472:pathogenicity*; D007274:Injections, Intraperitoneal; D051379:Mice; D009154:Mutation; D009368:Neoplasm Transplantation; D051381:Rats; D012517:Sarcoma, Yoshida / Q000276:immunology / Q000401:mortality; D014774:Virulence
D000900:Anti-Bacterial Agents; D003520:Cyclophosphamide